Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Pharming Group N.V.
< Previous
1
2
Next >
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
March 13, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders
March 04, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in March investor conference
February 28, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
February 27, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in February investor conference
February 10, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
January 21, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces public cash offer to the shareholders of Abliva AB
December 15, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces positive topline data in pediatric clinical trial of leniolisib
December 11, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in November investor conference
November 05, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports third quarter 2024 financial results and provides business update
October 24, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report third quarter 2024 financial results on October 24
October 10, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
October 10, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
September 26, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in September investor conferences
September 04, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports second quarter and first half 2024 financial results and provides business update
August 01, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report second quarter and first half 2024 financial results on August 1
July 18, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in June investor conferences
June 03, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
May 21, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in May investor conference
May 20, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports first quarter 2024 financial results and provides business update
May 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
April 24, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
April 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in April investor conferences
April 03, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports fourth quarter and full year 2023 financial results
March 14, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
February 29, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in February investor conferences
February 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
January 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
December 13, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
November 21, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in November investor conferences
November 01, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
